<DOC>
	<DOCNO>NCT00439647</DOCNO>
	<brief_summary>This study investigate drug zoledronic acid give yearly safe beneficial effect treat osteoporosis reduce bone loss fracture men osteoporosis .</brief_summary>
	<brief_title>Efficacy Reducing Fractures Safety Zoledronic Acid Men With Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>â€¢ Osteoporosis define low bone mineral density hip spine low bone mineral density hip combine presence 13 mild moderate fracture vertebrae Low Vitamin D Renal insufficiency Previous treatment certain antiosteoporotic therapy ( except certain washout period ) : calcitonin , bisphosphonates , parathyroid hormone ( PTH ) , sodium fluoride , strontium ranelate , Previous treatment testosterone , anabolic steroid growth hormone Chronic use systemic corticosteroid ( oral i.v . ) within last year History cancer metastasis within last 5 year History brittle bone disease , multiple myeloma , Paget 's disease , metabolic bone disease , except osteoporosis Bilateral hip replacements Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>male</keyword>
	<keyword>vertebral fracture</keyword>
	<keyword>clinical fracture</keyword>
	<keyword>bone mineral density</keyword>
	<keyword>bone biomarkers</keyword>
	<keyword>zoledronic acid</keyword>
</DOC>